Clinical Trials Logo

Clinical Trial Summary

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.


Clinical Trial Description

1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.

2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.

3. Compared with SEPSIS and CURB-65 grading system with the grading system we established. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04302688
Study type Observational
Source Renmin Hospital of Wuhan University
Contact
Status Completed
Phase
Start date December 10, 2019
Completion date March 4, 2020

See also
  Status Clinical Trial Phase
Completed NCT02246361 - Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Phase 4
Completed NCT00997555 - Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients N/A
Recruiting NCT05280873 - Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP Phase 1
Completed NCT00081315 - Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Phase 2
Active, not recruiting NCT04590547 - GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) Phase 2
Terminated NCT04370834 - Tocilizumab for Patients With Cancer and COVID-19 Disease Phase 2
Completed NCT02788643 - Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies
Active, not recruiting NCT04326725 - Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Completed NCT03012958 - Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Completed NCT03730428 - Everolimus Related Pneumonitis in MBC
Completed NCT04721444 - Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
Terminated NCT04040244 - Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis N/A
Terminated NCT03962725 - Avoiding Neuromuscular Blockers to Reduce Complications Phase 4
Recruiting NCT05455034 - Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis Phase 1/Phase 2